LIMP II Inhibitors
Chemical inhibitors classified under the LIMP II Inhibitors category typically work by indirectly altering the lysosomal environment, which is crucial for the functionality of lysosomal membrane proteins such as LIMP II. These compounds are characterized by their ability to modulate intralysosomal pH or affect lysosomal biogenesis and trafficking. For instance, agents like chloroquine and hydroxychloroquine are known to impair lysosomal acidification, thereby potentially impacting the stability and function of LIMP II.
Moreover, specific inhibitors like Bafilomycin A1 directly inhibit the V-ATPase, crucial for maintaining the acidic environment within lysosomes. Disruption of this environment can lead to improper functioning of lysosomal enzymes and membrane proteins, potentially leading to reduced LIMP II activity. Other compounds, such as U18666A and ketoconazole, impact lysosomal function by affecting lipid metabolism or membrane dynamics, which could destabilize lysosomal membrane proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
hydroxychloroquine | 118-42-3 | sc-507426 | 5 g | $57.00 | 1 | |
Similar to chloroquine, this compound can affect the acidification of lysosomes and potentially impair the function and stability of lysosomal membrane proteins like LIMP II. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
A specific inhibitor of the V-ATPase that prevents acidification of the lysosome, which could destabilize lysosomal membrane proteins including LIMP II. | ||||||
Amiodarone | 1951-25-3 | sc-480089 | 5 g | $318.00 | ||
An antiarrhythmic drug that also has lysosomotropic properties, which might disrupt lysosomal function and could affect LIMP II stability or expression. | ||||||
Imipramine hydrochloride | 113-52-0 | sc-207753 sc-207753B sc-207753A | 100 mg 1 g 5 g | $26.00 $45.00 $103.00 | 5 | |
A tricyclic antidepressant with lysosomotropic activity that can alter lysosomal pH and might influence the trafficking and function of lysosomal proteins like LIMP II. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
An ionophore that disrupts lysosomal acidification and could impair the function and processing of lysosomal membrane proteins, potentially including LIMP II. | ||||||
U 18666A | 3039-71-2 | sc-203306 sc-203306A | 10 mg 50 mg | $143.00 $510.00 | 2 | |
A cholesterol transport inhibitor that can induce changes in lysosomal cholesterol content and potentially affect lysosomal protein function and expression. | ||||||
Progesterone | 57-83-0 | sc-296138A sc-296138 sc-296138B | 1 g 5 g 50 g | $20.00 $52.00 $298.00 | 3 | |
This hormone can modulate cellular metabolism and may have indirect effects on lysosomal biogenesis and function, potentially impacting LIMP II. | ||||||
Ketoconazole | 65277-42-1 | sc-200496 sc-200496A | 50 mg 500 mg | $63.00 $265.00 | 21 | |
An antifungal agent that can disrupt membrane dynamics and may have off-target effects on lysosomal acidification and membrane protein stability. | ||||||